320 related articles for article (PubMed ID: 24637691)
1. Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.
Qureshi ZA; Syed A; Clarke LG; Doi Y; Shields RK
Antimicrob Agents Chemother; 2014 Jun; 58(6):3100-4. PubMed ID: 24637691
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
Brizendine KD; Richter SS; Cober ED; van Duin D
Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
[TBL] [Abstract][Full Text] [Related]
3. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
[TBL] [Abstract][Full Text] [Related]
5. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
van Duin D; Cober ED; Richter SS; Perez F; Cline M; Kaye KS; Kalayjian RC; Salata RA; Evans SR; Fowler VG; Bonomo RA
Clin Microbiol Infect; 2014 Dec; 20(12):O1117-20. PubMed ID: 24931918
[TBL] [Abstract][Full Text] [Related]
6. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
Ny P; Nieberg P; Wong-Beringer A
Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
[TBL] [Abstract][Full Text] [Related]
7. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.
Vergadi E; Bitsori M; Maraki S; Galanakis E
J Pediatr Urol; 2017 Oct; 13(5):495.e1-495.e6. PubMed ID: 28341427
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.
Shilo S; Assous MV; Lachish T; Kopuit P; Bdolah-Abram T; Yinnon AM; Wiener-Well Y
Infection; 2013 Apr; 41(2):503-9. PubMed ID: 23271210
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
Yeshitela B; Gebre-Selassie S; Feleke Y
Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic bacteriuria is an independent predictor of urinary tract infections in an ambulatory cirrhotic population: a prospective evaluation.
Ye C; Kumar D; Carbonneau M; Keough A; Ma M; Tandon P
Liver Int; 2014 Jul; 34(6):e39-44. PubMed ID: 24325582
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Carbapenem-resistant
Wang Z; Qin RR; Huang L; Sun LY
Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
[TBL] [Abstract][Full Text] [Related]
14. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Kalpoe JS; Sonnenberg E; Factor SH; del Rio Martin J; Schiano T; Patel G; Huprikar S
Liver Transpl; 2012 Apr; 18(4):468-74. PubMed ID: 22467548
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
Su CF; Chuang C; Lin YT; Chan YJ; Lin JC; Lu PL; Huang CT; Wang JT; Chuang YC; Siu LK; Fung CP
Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):651-659. PubMed ID: 29238934
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
Simkins J; Muggia V; Cohen HW; Minamoto GY
Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients.
Lu J; Zhang A; Han L; Guo Z; Cui W; Jiang Y; Meng H
Microbiol Spectr; 2023 Feb; 11(1):e0475522. PubMed ID: 36515527
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level.
Forde C; Stierman B; Ramon-Pardo P; Dos Santos T; Singh N
PLoS One; 2017; 12(5):e0176779. PubMed ID: 28542162
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.
Han JH; Goldstein EJ; Wise J; Bilker WB; Tolomeo P; Lautenbach E
Clin Infect Dis; 2017 Apr; 64(7):839-844. PubMed ID: 28013258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
